Argentine consensus on the diagnosis, monitoring and treatment of Pompe disease;Consenso argentino para el diagnóstico, seguimiento y tratamiento de la enfermedad de Pompe

Neurologia Argentina

Volumn 6, Issue 2, 2014, Pages 96-113

  Dubrovsky, Alberto ^a   Fulgenzi, Ernesto ^b   Amartino, Hernán ^c   Carlés, Daniel ^d   Corderi, José ^a   de Vito, Eduardo ^e,r   Fainboim, Alejandro ^g   Ferradás, Nélida ^h   Guelbert, Norberto ⁱ   Lubieniecki, Fabiana ^j   Mazia, Claudio ^e   Mesa, Lilia ^a   Monges, Soledad ^j   Pesquero, Joao ^k   Reisin, Ricardo ^l   Rugiero, Marcelo ^m   Schenone, Andrea ⁿ   Szlago, Marina ⁿ   Taratuto, Ana Lia ^o   Zgaga, Marisa ^p,q  

^a HOSPITAL UNIVERSITARIO FUNDACIÓN FAVALORO   (Argentina)

^b Unidad Asistencial Dr César Milstein ^*  (Argentina)

^c UNIVERSIDAD AUSTRAL   (Argentina)

^d Hospital Perrando   (Argentina)

^e INSTITUTO DE INVESTIGACIONES MÉDICAS ALFREDO LANARI   (Argentina)

^f Cuidados Respiratorios Buenos Aires   (Argentina)

^g HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

^h International Life Sciences Institute (ILSI)   (Argentina)

ⁱ Hospital de Ninos de la Santisima Trinidad   (Argentina)

^j Hospital de Pediatria SAMIC Prof Dr Juan P Garrahan   (Argentina)

^k FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^l HOSPITAL BRITÁNICO DE BUENOS AIRES   (Argentina)

^m HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

ⁿ Hospital Italiano ^*  (Argentina)

^o Instituto de Investigaciones Neurologicas Raul Carrera   (Argentina)

^p Hospital Eva Peron   (Argentina)

^q Instituto Lucha Antipoliomielítica de Rosario ILAR   (Argentina)

^r Instituto de Lucha Antipoliomielítica y Rehabilitación Del Lisiado ^*  (Argentina)

more..

Author keywords

Acid alpha glucosidase; Consensus; Enzyme replacement therapy; Glycogen storage disease type ii; Lysosomal acid maltase deficiency; Pompe disease

Indexed keywords

ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; CONFLICT OF INTEREST; CONSENSUS; DISEASE SURVEILLANCE; GLYCOGEN STORAGE DISEASE TYPE 2; LABORATORY DIAGNOSIS; MEDICAL EXPERT; PATHOPHYSIOLOGY; PRACTICE GUIDELINE;

EID: 84901943319     PISSN: 18530028     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuarg.2014.01.006     Document Type: Article

References (163)

1. W.R. Wilcox Lysosomal storage disorders: The need for better pediatric recognition and comprehensive care J Pediatr 144 5 Suppl 2004 S3 S14
2. P.J. Meikle, J.J. Hopwood, A.E. Clague, and W.F. Carey Prevalence of lysosomal storage disorders JAMA 281 1999 249 254 (Pubitemid 29058114)
3. B.J. Poorthuis, R.A. Wevers, W.J. Kleijer, J.E. Groener, J.G. de Jong, and S. van Weely et al. The frequency of lysosomal storage diseases in The Netherlands Hum Genet 105 1999 151 156 (Pubitemid 29396979)
4. H.G. Hers Alpha-glucosidase deficiency in generalized glycogen storage disease (Pompe's disease) Biochem J 86 1963 11 16
5. B.L. Thurberg, C. Lynch Maloney, C. Vaccaro, K. Afonso, A.C. Tsai, and E. Bossen et al. Characterization of pre- and post-treatment pathology after enzyme replacement therapy for Pompe disease Lab Invest 86 2006 1208 1220 (Pubitemid 44789911)
6. R. Hirschhorn, and A.J.J. Reuser Glycogen storage disease type ii: Acid alpha-glucosidase (acid maltase) deficiency R.C. Schriver, A.L. Beaudet, W.S. Sly, D. Valle, The metabolic and molecular bases of inherited disease 2001 McGraw-Hill New York 3389 3420
7. P.S. Kishnani, and R.R. Howell Pompe disease in infants and children J Pediatr 144 5 Suppl 2004 S35 S43
8. T. Fukuda, M. Ahearn, A. Roberts, R.J. Mattaliano, K. Zaal, and E. Ralston et al. Autophagy and mistargeting of therapeutic enzyme in skeletal muscle in Pompe disease Mol Ther 6 2006 831 839 (Pubitemid 44743133)
9. Dubrovsky A, Corderi J, Karasarides T, Taratuto AL. Pompe disease, the must-not-miss diagnosis: A report of 3 patients. Muscle Nerve. 2013;47:594-600.
10. P.S. Kishnani, R.D. Steiner, D. Bali, K. Berger, B.J. Byrne, and L.E. Case et al. Pompe disease diagnosis and management guideline Genet Med 8 2006 267 288 (Pubitemid 44297314)
11. F. Martiniuk, A. Chen, A. Mack, E. Arvanitopoulos, Y. Chen, and W.N. Rom et al. Carrier frequency for glycogen storage disease type ii in New York and estimates of affected individuals born with the disease Am J Med Genet 79 1998 69 72 (Pubitemid 28402423)
12. M. Kroos, M. Hoogeveen-Westerveld, A. van der Ploeg, and A.J.J. Reuser The genotype-phenotype correlation in Pompe disease Am J Med Genet C Semin Med Genet 160 2012 59 68
13. J. Van Gijn, and J.P. Gijselhart Pompe and his disease Ned Tijdschr Geneeskd 155 2011 A2878
14. J.C. Pompe Over idiopatische hypertrophie van het hart Ned Tidschr Geneeskd 76 1932 304 311
15. L.A. Zeidman, C. Johannes, and M.D. Pompe hero of neuroscience: The man behind the syndrome Muscle Nerve 46 2012 134 138
16. N. Raben, A. Wong, E. Ralston, and R. Myerowitz Autophagy and mitochondria in Pompe disease: Nothing is so new as what has long been forgotten Am J Med Genet C Semin Med Genet 160 2012 13 21
17. Cori GT. Biochemical aspects of glycogen deposition disease. Bibl Paediat. 1958;14:344-58.
18. Engel AG, Seybold ME, Lambert EH, Gomez MR. Acid maltase deficiency: Comparison of infantile, childhood, and adult types. Neurology. 1970;20:382.
19. J. Honig, F. Martiniuk, P. D'Eustachio, C. Zamfirescu, R. Desnick, and K. Hirschhorn et al. Confirmation of the regional localization of the genes for human acid alpha-glucosidase (GAA) and adenosine deaminase (ADA) by somatic cell hybridization Ann Hum Genet 48 Pt 1 1984 49 56 (Pubitemid 14004941)
20. T. De Barsy, P. Jacquemin, F. van Hoof, and H.G. Hers Enzyme replacement in Pompe disease: An attempt with purified human acid alpha-glucosidase Birth Defects Orig Artic Ser 9 1973 184 190
21. P.S. Kishnani, M. Nicolino, T. Voit, R.C. Rogers, A.C. Tsai, and J. Waterson et al. Chinese hamster ovary cell-derived recombinant human acid alpha-glucosidase in infantile-onset Pompe disease J Pediatr 149 2006 89 97 (Pubitemid 44081924)
22. Van der Ploeg AT, Clemens PR, Corzo D, Escolar DM, Florence J, Groeneveld GJ, et al. A randomized study of alglucosidase alfa in late-onset Pompe's disease. N Engl J Med. 2010;362:1396-406.
23. E.J. Cupler, K.I. Berger, R.T. Leshner, G.I. Wolfe, J.J. Han, R.J. Barohn AANEM Consensus Committee on Late-onset Pompe Disease Consensus treatment recommendations for late-onset Pompe disease Muscle Nerve 45 2012 319 333
24. N. Raben, P. Plotz, and B.J. Byrne Acid alpha-glucosidase deficiency (glycogenosis type ii Pompe disease) Curr Mol Med 2 2002 145 166 (Pubitemid 34649837)
25. American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) Diagnostic criteria for late-onset (childhood and adult) Pompe, disease Muscle Nerve 40 2009 149 160
26. N. Raben, A. Roberts, and P.H. Plotz Role of autophagy in the pathogenesis of Pompe disease Acta Myol 26 2007 45 48 (Pubitemid 47400724)
27. P.S. Kishnani, A.A. Beckemeyer, and N.J. Mendelsohn The new era of Pompe disease: Advances in the detection, understanding of the phenotypic spectrum, pathophysiology, and management Am J Med Genet C Semin Med Genet 160 2012 1 7
28. N. Raben, S. Takikita, M.G. Pittis, B. Bembi, S.K. Marie, and A. Roberts et al. Deconstructing Pompe disease by analyzing single muscle fibers: To see a world in a grain of sand Autophagy 3 2007 546 552 (Pubitemid 350060050)
29. P.S. Kishnani, W.L. Hwu, H. Mandel, M. Nicolino, F. Yong, and D. Corzo A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease J Pediatr 148 2006 671 676
30. D. Marsden Infantile onset Pompe disease: A report of physician narratives from an epidemiologic study Genet Med 7 2005 147 150 (Pubitemid 40261842)
31. H.M. Van den Hout, W. Hop, O.P. van Diggelen, J.A. Smeitink, G.P. Smit, and B.T. Poll-The et al. The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature Pediatrics 112 2003 332 340 (Pubitemid 36951395)
32. R.R. Howell, B. Byrne, B.T. Darras, P. Kishnani, M. Nicolino, and A. van der Ploeg Diagnostic challenges for Pompe disease: An under-recognized cause of floppy baby syndrome Genet Med 8 2006 289 296 (Pubitemid 44297315)
33. M. Di Rocco, D. Buzzi, and M. Taro Glycogen storage disease type ii: Clinical overview Acta Myol 26 2007 42 44 (Pubitemid 47400723)
34. A.E. Slonim, L. Bulone, S. Ritz, T. Goldberg, A. Chen, and F. Martiniuk Identification of two subtypes of infantile acid maltase deficiency J Pediatr 137 2000 283 285 (Pubitemid 30659245)
35. Desnuelle C, Salviati L. Challenges in diagnosis and treatment of late-onset Pompe disease. Current Opinion in Neurology. 2011;24:443-8.
36. C. Fernández, A.M. de Paula, D. Figarella-Branger, M. Krahn, R. Giorgi, and B. Chabrol et al. Diagnostic evaluation of clinically normal subjects with chronic hyperCKemia C Neurology 66 2006 1585 1587 (Pubitemid 43958564)
37. M.A. Barba-Romero, E. Barrot, J. Bautista-Lorite, E. Gutiérrez- Rivas, I. Illa, and L.M. Jiménez et al. Guía clínica de la enfermedad de Pompe de inicio tardío Rev Neurol 54 2012 497 507
38. M.L. Hagemans, L.P. Winkel, P.A. van Doorn, W.J. Hop, M.C. Loonen, and A.J. Reuser et al. Clinical manifestation and natural course of late onset Pompe's disease in 54 Dutch patients Brain 128 2005 671 677 (Pubitemid 40380201)
39. J.H. Wokke, D.M. Escolar, A. Pestronk, K.M. Jaffe, G.T. Carter, and L.H. van den Berg et al. Clinical features of late-onset Pompe disease: A prospective cohort study Muscle Nerve 38 2008 1236 1245
40. P. Laforet, V. Doppler, C. Caillaud, K. Laloui, K.G. Claeys, and P. Richard et al. Rigid spine syndrome revealing late-onset Pompe disease Neuromuscul Disord 20 2010 128 130
41. Kostera-Pruszczyk A, Opuchlik A, Lugowska A, Nadaj A, Bojakowski J, Tylki-Szymanska A, et al. Juvenile onset acid maltase deficiency presenting as a rigid spine syndrome. Neuromuscul Disord. 2006;16:282-5. Epub 2006Mar 13.
42. M. Roberts, P.S. Kishnani, A.T. van der Ploeg, W. Müller-Felber, L. Merlini, and S. Prasad et al. The prevalence and impact of scoliosis in Pompe disease: Llessons learned from the Pompe Registry Mol Genet Metab 104 2011 574 582 Epub 2011 Aug 16
43. A. Dubrovsky, J. Corderi, M. Lin, P.S. Kishnani, and H.N. Jones Expanding the phenotype of late-onset Pompe disease: Tongue weakness: A new clinical observation Muscle Nerve 44 2011 897 901
44. D. Barnes, R.A. Hughes, and G.T. Spencer Adult-onset acid maltase deficiency with prominent bulbar involvement and ptosis J R Soc Med 86 1993 50 (Pubitemid 23012182)
45. A.A. Amato Acid maltase deficiency and related myopathies Neurol Clin 18 2000 161 165
46. R.J. Barohn, A.L. McVey, and S. Di Mauro Adult acid maltase deficiency Muscle Nerve 16 1993 672 676 (Pubitemid 23157340)
47. A.G. Engel, M.R. Gomez, M.E. Seybold, and E.H. Lambert The spectrum and diagnosis of acid maltase deficiency Neurology 23 1973 95 106
48. A.J. Reuser, M.A. Kroos, M.M. Hermans, A.G. Bijvoet, M.P. Verbeet, and O.P. Van Diggelen et al. Glycogenosis type ii (acid maltase deficiency) Muscle Nerve 3 1995 S61 S69
49. M.L. Hagemans, A.C. Janssens, L.P. Winkel, K.A. Sieradzan, A.J. Reuser, and P.A. Van Doorn et al. Late-onset Pompe disease primarily affects quality of life in physical health domains Neurology 63 2004 1688 1692 (Pubitemid 39507589)
50. Bembi B, Cerini E, Danesino C, Donatti MA, Gasperini S, Morando L, et al. Diagnosis of glycogenosis type ii. Neurology. 2008;71 Suppl 2:S4-11.
51. Kishnani PS, Hwu WL, Mandel H, Nicolino M, Yong F, Corzo D; Infantile-Onset Pompe Disease Natural History Study Group. A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease. J Pediatr. 2006 May;148:671-76.
52. R. Hirschhorn, and A.J.J. Reuser Glycogen storage disease type ii: Acid a-glucosidase (acid maltase) deficiency D. Valle, C.R. Scriver, Scriver's OMMBID the online metabolic & molecular bases of inherited disease 2010 McGraw-Hill New York
53. P. Laforêt, M. Nicolino, P.B. Eymard, J.P. Puech, C. Caillaud, and L. Poenaru et al. Juvenile and adult-onset acid maltase deficiency in France: Genotype-phenotype correlation Neurology 55 2000 1122 1128
54. E.L. De Vito, S.G. Monteiro, and P.K. Aruj Compromiso del centro respiratorio en pacientes con enfermedad de Pompe de inicio adulto Respirar 6 Supl. 2012 143
55. L.W. Katzin, and A.A. Amato Pompe disease: a review of the current diagnosis and treatment recommendations in the era of enzyme replacement therapy J Clin Neuromuscul Dis 9 2008 421 431
56. U. Mellies, R. Ragette, C. Schwake, M. Baethmann, T. Voit, and H. Teschler Sleep-disordered breathing and respiratory failure in acid maltase deficiency Neurology 57 2001 1290 1295 (Pubitemid 32947390)
57. N.A. Moufarrej, and T.E. Bertorini Respiratory insufficiency in adult-type acid maltase deficiency South Med J 86 1993 560 567 (Pubitemid 23150700)
58. D.G. Kim, K. Jung, M.K. Lee, I.G. Hyun, H.J. Lim, and H.G. Song et al. A case of juvenile form Pompe's disease manifested as chronic alveolar hypoventilation J Korean Med Sci 8 1993 221 224
59. R.W. Keunen, P.C. Lambregts, A.A. Op de Coul, and E.M. Joosten Respiratory failure as initial symptom of acid maltase deficiency J Neurol Neurosurg Psychiatry 47 1984 549 552 (Pubitemid 14145507)
60. Domínguez Flores ME, Luna Padrón E, Penãlosa Ochoa L, Galicia Amor S, Toral Freyre S, Banõs Mejía BO, et al., Grupo de Consenso para el Diagnóstico y Tratamiento de las Alteraciones Respiratorias en las Enfermedades Neuromusculares. Guía para el diagnóstico y tratamiento de las alteraciones respiratorias en las enfermedades neuromusculares. Neumol Cir Torax. 2011;70:5-70 [consultado 7 Oct 2013]. Disponible en: http://www.medigraphic.com/neumologia.
61. C. Perrin, C. D'Ambrosio, A. White, and N.S. Hill Sleep in restrictive and neuromuscular respiratory disorders Semin Respir Crit Care Med 26 2005 117 130 (Pubitemid 40315558)
62. N.S. Ward, and N.S. Hill Pulmonary function testing in neuromuscular disease Clin Chest Med 22 2001 769 781 (Pubitemid 34020013)
63. M.L. Margolis, P. Howlett, R. Goldberg, A. Eftychiadis, and S. Levine Obstructive sleep apnea syndrome in acid maltase deficiency Chest 105 1994 947 949 (Pubitemid 24088493)
64. U. Mellies, C. Dohna-Schwake, and T. Voit Respiratory function assessment and intervention in neuromuscular disorders Curr Opin Neurol 18 2005 543 547 (Pubitemid 41476140)
65. U. Mellies, F. Stehling, C. Dohna-Schwake, R. Ragette, H. Teschler, and T. Voit Respiratory failure in Pompe disease: Treatment with noninvasive ventilation Neurology 64 2005 1465 1467 (Pubitemid 40570526)
66. N. Pellegrini, P. Laforêt, D. Orlikowski, M. Pellegrini, C. Caillaud, and B. Eymard et al. Respiratory insufficiency and limb muscle weakness in adults with Pompe's disease Eur Respir J 26 2005 1024 1031 (Pubitemid 41829932)
67. A.T. Van der Ploeg Monitoring of pulmonary function in Pompe disease: A muscle disease with new therapeutic perspectives Eur Respir J 26 2005 984 985
68. American Thoracic Society/European Respiratory Society (ATS/ERS) statement on respiratory muscle testing Am J Respir Crit Care Med 166 2002 518 624
69. E.L. De Vito, and A. Grassino Respiratory muscle fatigue: Rationale for diagnostic test. Part C: Disease. Diagnosis C. Roussos, The Thorax 2nd ed. 1995 Marcel y Dekker Inc New York
70. K.I. Berger, A. Skrinar, and R.G. Norman Ventilatory dysfunction in late onset Pompe disease Proc Am Thorac Soc 2 2005 A788
71. R.M. Kravitz, J. Mackey, S. DeArmey, and P.S. Kishnani Pulmonary function findings in patients with infantile Pompe disease Proc Am Thorac Soc 2 2005 A186
72. S. Redline, V.K. Kapur, M.H. Sanders, S.F. Quan, D.J. Gottlieb, and D.M. Rapoport et al. Effects of varying approaches for identifying respiratory disturbances on sleep apnea assessment Am J Respir Crit Care Med 161 2000 369 374 (Pubitemid 30129440)
73. T. Young, M. Palta, J. Dempsey, J. Skatrud, S. Weber, and S. Badr The occurrence of sleep-disordered breathing among middle-aged adults N Engl J Med 328 1993 1230 1235 (Pubitemid 23115702)
74. J.D. Metzl, E.R. Elias, and C.I. Berul An interesting case of infant sudden death: Severe hypertrophic cardiomyopathy in Pompe's disease Pacing Clin Electrophysiol 22 1999 821 822 (Pubitemid 29245001)
75. R.M. Kravitz, J. Mackey, S. DeArmey, and P.S. Kishnani Polysomnogram findings in patients with infantile Pompe disease Proc Am Thorac Soc 2 2005 A459
76. C.A. Kushida, M.R. Littner, T. Morgenthaler, C.A. Alessi, D. Bailey, and J. Coleman Jr et al. Practice parameters for the indications for polysomnography and related procedures: An update for 2005 Sleep 28 2005 499 521 (Pubitemid 40489844)
77. W. Müller-Felber, R. Horvath, K. Gempel, T. Podskarbi, Y. Shin, and D. Pongratz et al. Late onset Pompe disease: Clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients Neuromuscul Disord 17 2007 698 706 (Pubitemid 47362681)
78. T.A. Trikalinos, S. Ip, G. Raman, M.S. Cepeda, E.M. Balk, and C. D'Ambrosio et al. Home diagnosis of obstructive sleep apnea-hypopnea syndrome 2007 Agency for Healthcare Research and Quality Rockville 1 127
79. L.P. Winkel, M.L. Hagemans, P.A. van Doorn, M.C. Loonen, W.J. Hop, and A.J. Reuser et al. The natural course of non-classic Pompe's disease; a review of 225 published cases J Neurol 252 2005 875 884 (Pubitemid 41186956)
80. E.C. Rosenow, and A.G. Engel Acid maltase deficiency in adults presenting as respiratory failure Am J Med 64 1978 485 491 (Pubitemid 8302307)
81. B. Mokhlesi, A. Tulaimat, I. Faibussowitsch, Y. Wang, and A.T. Evans Obesity hypoventilation syndrome: Prevalence and predictors in patients with obstructive sleep apnea Sleep Breath 11 2007 117 124 (Pubitemid 46745864)
82. O.I. Soliman, N.A. van der Beek, P.A. van Doorn, W.B. Vletter, A. Nemes, and B.M. van Dalen et al. Cardiac involvement in adults with Pompe disease J Intern Med 264 2008 333 339
83. J.D. Finder, D. Birnkrant, J. Carl, H.J. Farber, D. Gozal, and S.T. Iannaccone et al. American Thoracic Society Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement Am J Respir Crit Care Med 170 2004 456 465 (Pubitemid 39214623)
84. M. Chatwin, E. Ross, N. Hart, A.H. Nickol, M.I. Polkey, and A.K. Simonds Cough augmentation with mechanical insufflation/exsufflation in patients with neuromuscular weakness Eur Respir J 21 2003 502 508 (Pubitemid 36336212)
85. LCD, for Respiratory Assist Devices (L27228), National Government Services, website 2011 [consultado 7 Oct10 2013]. Disponible en: http://apps.ngsmedicare.com/applications/Content.aspx?DOCID21448&CatID3& RegI 51& ContentID34363
86. Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD and nocturnal hypoventilation - a consensus conference report Chest 116 1999 521 534
87. M. Aubier, D. Murciano, J. Milic-Emili, E. Touaty, J. Daghfous, and R. Pariente et al. Effects of the administration of O2 on ventilation and blood gases in patients with chronic obstructive pulmonary disease during acute respiratory failure Am Rev Respir Dis 122 1980 747 754 (Pubitemid 11194222)
88. A.T. Van der Ploeg, R. Barohn, L. Carlson, J. Charrow, P.R. Clemens, and R.J. Hopkin et al. Open-label extension study following the Late-Onset Treatment Study (LOTS) of alglucosidase alfa Mol Genet Metab 107 2012 456 461
89. C. Angelini, C. Semplicini, S. Ravaglia, B. Bembi, S. Servidei, and M. Moggio et al. Long-term follow-up effects on enzyme replacement treatment of adult form of acid maltase deficiency myopathy Acta Myol 30 2011 152
90. A. Toscano, and B. Schoser Enzyme replacement therapy in late-onset Pompe disease: A systematic literature review J Neurol 260 2013 951 959
91. Levine JC, Kishnani PS, Chen YT, Herlong JR, Li JS. Cardiac remodeling after enzyme replacement therapy with acid _-glucosidase for infants with Pompe disease. Pediatr Cardiol. 2008;29:1033-42.
92. Barker PC, Pasquali SK, Darty S, Ing RJ, Li JS, Kim RJ, et al. Use of cardiac magnetic resonance imaging to evaluate cardiac structure, function and fibrosis in children with infantile Pompe disease on enzyme replacement therapy. Mol Genet Metab. 2010;101:332-7.
93. Chen CA, Chien YH, Hwu WL, Lee NC, Wang JK, Chen LR, et al. Left ventricular geometry, global function, and dyssynchrony in infants and children with Pompe cardiomyopathy undergoing enzyme replacement therapy. J Card Fail. 2011;17:930-6.
94. Winchester B, Bali D, Bodamer OA, Caillaud C, Christensen E, Cooper A, et al. Method for a prompt and reliable laboratory diagnosis of Pompe disease: Report from an international consensus meeting. Mol Genet Metab. 2008;93:275-81.
95. M.H. Gelb, F. Turecek, C.R. Scott, and N.A. Chamoles Direct multiplex assay of enzymes in dried blood spots by tandem mass spectrometry for the newborn screening of lysosomal storge disorders J Inherit Metab Dis 29 2008 397 404
96. S.P. Young, D. Corzo, and P. Kishnani Diagnostic value of urinay and plasma tetrasaccharides in infantile and late onset glycogen storage disease type ii Mol Genet Metab 84 2005 241 242
97. A.L. Taratuto, A. Dubrovsky, and J. Corderi Misleading muscle biopsies in late onset Pompe's disease Neuromuscular Disorders 19 2009 591
98. A.L. Taratuto, Dubrovsky, and J. Corderi Non-diagnostic muscle biopsies in late onset Pompe's Disease J Neuropathol Exp Neurol 70 2011 533
99. The online metabolic and molecular bases of metabolic diseases, 2008. Disponible en: http://www.ommbid.com
100. Y.-H. Chien, and W.-L. Hwu A review of treatment of Pompe disease in infants Biologics 1 2007 195 201
101. M.A. Kroos, R.J. Pomponio, M.L. Hagemans, J.L. Keulemans, M. Phipps, and M. DeRiso et al. Broad spectrum of Pompe disease in patients with the same c.-32-13T->G haplotype Neurology 68 2007 110 115 (Pubitemid 46071893)
102. C. Regnery, C. Kornblum, F. Hanisch, S. Vielhaber, N. Strigl-Pill, and B. Grunert et al. 36 months observational clinical study of 38 adult Pompe disease patients under alglucosidase alfa enzyme replacement therapy J Inherit Metab Dis 35 2012 837 845
103. M. Hoeksma, M. Boon, K.E. Niezen-Koning, L. van Overbeek-van Gils, and F.J. van Spronsen Isolated elevated serum transaminases leading to the diagnosis of asymptomatic Pompe disease Eur J Pediatr 166 2007 871 874 Epub 2006 Oct 17 (Pubitemid 46988166)
104. Kimura J. Electrodiagnosis in diseases of nerve and muscle: Principles and practice. 3rd ed. New York: Oxford University Press; 2001.
105. A. Alejaldre, J. Díaz-Manera, S. Ravaglia, E.C. Tibaldi, F. D'Amore, and G. Morís et al. Trunk muscle involvement in late-onset Pompe disease: Study of thirty patients Neuromuscul Disord 22 Suppl 2 2012 S148 S154
106. Carlier RY, Laforet P, Wary C, Mompoint D, Laloui K, Pellegrini N, et al. Whole-body muscle MRI in 20 patients suffering from late onset Pompe disease: Involvement patterns. Neuromuscul Disord. 2011;21:791-9, doi:10.1016/j.nmd.2011.06.748 Epub 2011 Jul 30.
107. S.P. Sayers, P.M. Clarkson, P.A. Rouzier, and G. Kamen Adverse events associated with eccentric exercise protocols: Six case studies Med Sci Sports Exerc 31 1999 1697 1702 (Pubitemid 30012883)
108. R.T. Abresch, J.J. Han, and G.T. Carter Rehabilitation management of neuromuscular disease: The role of exercise training J Clin Neuromuscul Dis 11 2009 7 21
109. Clarkson PM. Exercise-induced muscle damage-animal and human models. Med Sci Sports Exerc. 1992;24: 510-1.
110. L.E. Case, and P.S. Kishnani Physical therapy management of Pompe disease Genet Med 8 2006 318 332
111. A.E. Slonim, L. Bulone, T. Goldberg, J. Minikes, E. Slonim, and J. Galanko et al. Modification of the natural history of adult-onset acid maltase deficiency by nutrition and exercise therapy Muscle Nerve 35 2007 70 77 (Pubitemid 46052651)
112. G. Terzis, F. Dimopoulos, G.K. Papadimas, C. Papadopoulos, K. Spengos, and I. Fatouros et al. Effect of aerobic and resistance exercise training on late-onset Pompe disease patients receiving enzyme replacement therapy Mol Genet Metab 104 2011 279 283
113. D.B. Olsen, M.C. Orngreen, and J. Vissing Aerobic training improves exercise performance in facioscapulohumeral muscular dystrophy Neurology 64 2005 1064 1066 (Pubitemid 40388464)
114. M.C. Orngreen, D.B. Olsen, and J. Vissing Aerobic training in patients with myotonic dystrophy type 1 Ann Neurol 57 2005 754 757 (Pubitemid 40628867)
115. M.L. Sveen, T.D. Jeppesen, S. Hauerslev, L. Køber, T.O. Krag, and J. Vissing Endurance training improves fitness and strength in patients with Becker muscular dystrophy Brain 131 Pt 11 2008 2824 2831 doi:10.1093/brain/ awn189 Epub 2008 Sep 6
116. J. Griffin Infantile acid maltase deficiency. I. Muscle fiber destruction after lysosomal rupture Virchows Arch B Cell Pathol Incl Mol Pathol 45 1984 23 36 (Pubitemid 14175482)
117. Fowler Jr WM. Role of physical activity and exercise training in neuromuscular diseases. Am J Phys Med Rehabil. 2002;81 Suppl:S187-95.
118. M. Eagle Report on the muscular dystrophy campaign workshop: Exercise in neuromuscular diseases Newcastle Neuromuscul Disord 12 2002 975 983 (Pubitemid 35414372)
119. M.I. Nilsson, I.A. Samjoo, B.P. Hettinga, D.D. Koeberl, H. Zhang, and T.J. Hawke et al. Aerobic training as an adjunctive therapy to enzyme replacement in Pompe disease Mol Genet Metab 107 2012 469 479
120. Favejee MM, Huisstede BM, Bussmann JB, Kruijshaar ME, van der Ploeg AT. Physiotherapy management in late-onset Pompe disease: Clinical practice in 88 patients. Mol Genet Metab. 2012;107:111-5.
121. B. Bembi, G. Ciana, C. Martini, A. Benettoni, A. Gombacci, and M. Deganuto et al. Efficacy of multidisciplinary approach in the treatment of two cases of nonclassical infantile glycogenosis type ii J Inherit Metab Dis 26 2003 675 681 (Pubitemid 38008972)
122. Terzis G, Krase A, Papadimas G, Papadopoulos C, Kavouras S, Manta P. Effects of exercise training during infusion on late-onset Pompe disease patients receiving enzyme replacement therapy. Mol Genet Metab. 2012;107:669-73.
123. C.M. McDonald Limb contractures in progressive neuromuscular disease and the role of stretching, orthotics and surgery Phys Med Rehabil Clin N Am 9 1998 187 211 (Pubitemid 28134027)
124. M. Kinali, S. Messina, E. Mercuri, J. Lehovsky, G. Edge, and A.Y. Manzur et al. Management of scoliosis in Duchenne muscular dystrophy: A large 10-year retrospective study Dev Med Child Neurol 48 2006 513 518 (Pubitemid 43740916)
125. S. Cervellati, N. Bettini, M. Moscato, A. Gusella, E. Dema, and R. Maresi Surgical treatment of spinal deformities in Duchenne muscular dystrophy: A long term follow-up study Eur Spine J 13 2004 441 448 (Pubitemid 39141506)
126. T. Oda, N. Shimizu, K. Yonenobu, K. Ono, T. Nabeshima, and S. Kyoh Longitudinal study of spinal deformity in Duchenne muscular dystrophy J Pediatr Orthop 13 1993 478 488 (Pubitemid 23174658)
127. C. Granata, L. Merlini, S. Cervellati, A. Ballestrazzi, S. Giannini, and M. Corbascio et al. Long-term results of spine surgery in Duchenne muscular dystrophy Neuromuscul Disord 6 1996 61 68 (Pubitemid 26016502)
128. F. Miller, C.F. Moseley, and J. Koreska Spinal fusion in Duchenne muscular dystrophy Dev Med Child Neurol 34 1992 775 786
129. L.E. Van den Berg, A.A. Zandbergen, C.I. van Capelle, J.M. de Vries, W.C. Hop, and J.M. Van den Hout et al. Low bone mass in Pompe disease: Muscular strength as a predictor of bone mineral density Bone 47 2010 643 649
130. J.C. Llerena, D.M. Horovitz, S.K. Marie, G. Porta, R. Giugliani, and M.W. Munoz et al. The Brasilian consensus on the management of Pompe disease J Pediatr 155 2009 47 56
131. Hobson-Webb LD, Jones HN, Priya S, Kishnani PS. Oropharyngeal dysphagia may occur in late-onset Pompe disease, implicating bulbar muscle involvement. Neuromuscul Disord. 2013;23:319-23.
132. D.L. Bernstein, M.G. Bialer, L. Mehta, and R.J. Desnick Pompe disease: Dramatic improvement in gastrointestinal function following enzyme replacement therapy. A report of three later-onset patients Mol Genet Metab 101 2010 130 133
133. S. Ravaglia, A. Pichiecchio, M. Rossi, P.D. Filippi, A. Minelli, and A. Moglia et al. Dietary treatment in adult-onset type ii glycogenosis J Inherit Metab Dis 29 2006 590
134. Slonim AE, Bulone L, Minikes J, Hays AP, Shanske S, Tsujino S, et al. Benign course of glycogen storage disease type iib in two brothers: Nature or nurture? Muscle Nerve. 2006;33:571-4.
135. G. Hug, W.K. Schubert, and S. Soukup Treatment related observations in solid tissues, fibroblast cultured and amniotic fluid cells of type ii glycogenosis, Hurler disease and metachromatic leukodystrophy Birth Defects Orig Art Ser 9 1973 160 183
136. O.A. Bodamer, D. Halliday, and J.V. Leonard The effects of l-alanine supplementation in late-onset glycogen storage disease type ii Neurology 55 2000 710 712
137. Bodamer OA, Haas D, Hermans MM, Reuser AJ, Hoffmann GF. L-alanine supplementation in late infantile glycogen storage disease type ii. Pediatr Neurol. 2002;27:145-6.
138. A.E. Slonim, R.A. Coleman, M.A. McElligot, J. Najjar, K. Hirschhorn, and G.U. Labadie et al. Improvement of muscle function in acid maltase deficiency by high-protein therapy Neurology 33 1983 34 38 (Pubitemid 13171155)
139. O.A. Bodamer, J.V. Leonard, and D. Halliday Dietary treatment in late-onset acid maltase deficiency Eur J Pediatr 156 1997 S39 S42
140. C. Angelini, E. Pegorora, S.Z. Marsala, L. Vergani, A.C. Nascimbeni, L. Fulizio, and M. Fanin Adult acid maltase deficiency: An open trial with albuterol and branched chain amino acids Basic Appl Myol 14 2004 71 78
141. J.G. Watson, D. Gardner-Medwin, M.E. Goldfinch, and A.D. Pearson Bone marrow transplantation for glycogen storage disease type ii (Pompe's disease) N Engl J Med 314 1986 385 (Pubitemid 16166268)
142. P.J. Meikle, D.J. Grasby, C.J. Dean, D.L. Lang, M. Bockmann, and A.M. Whittle et al. Newborn screening for lysosomal storage disorders Mol Genet Metab 88 2006 307 314 Epub 2006 Apr 4 (Pubitemid 44107765)
143. P.S. Kishnani, D. Corzo, M. Nicolino, B. Byrne, H. Mandel, and W.L. Hwu et al. Recombinant human acid alpha-glucosidase: Major clinical benefits in infantile-onset Pompe disease Neurology 68 2007 99 109 (Pubitemid 46071892)
144. T.M. Geel, P.M. McLaughlin, L.F. de Leij, M.H. Ruiters, and K.E. Niezen-Koning Pompe disease: Current state of treatment modalities and animal models Mol Genet Metab 92 2007 299 307 (Pubitemid 350123729)
145. H. Van den Hout, A.J. Reuser, A.G. Vulto, M.C. Loonen, A. Cromme-Dijkhuis, and A.T. van der Ploeg Recombinant human alpha-glucosidase from rabbit milk in Pompe patients Lancet 356 2000 397 398 (Pubitemid 30487498)
146. J.M. Van den Hout, A.J. Reuser, J.B. de Klerk, W.F. Arts, J.A. Smeitink, and A.T. Van der Ploeg et al. Enzyme therapy for Pompe disease with recombinant human alpha-glucosidase from rabbit milk J Inherit Metab Dis 24 2001 266 274 (Pubitemid 32479420)
147. Amalfitano A, Bengur AR, Morse RP, Majure JM, Case LE, Veerling DL, et al. Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase i/ii clinical trial. Genet Med. 2001;3:132-8.
148. L. Klinge, V. Straub, U. Neudorf, J. Schaper, T. Bosbach, and K. Görlinger et al. Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: Results of a phase ii clinical trial Neuromuscul Disord 15 2005 24 31 (Pubitemid 41556629)
149. P. Meikle, E. Ranieri, H. Simonsen, T. Rozaklis, S.L. Ramsay, and P.D. Whitfield et al. Newborn screening for lysosomal storage disorders: Clinical evaluation of a two-tier strategy Pediatrics 114 2004 909 916 (Pubitemid 41529752)
150. J.M. Van den Hout, J.H. Kamphoven, L.P. Winkel, W.E. Arts, J.B. De Klerk, and M.C. Loonen et al. Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk Pediatrics 113 2004 e448 e457
151. L.P. Winkel, J.H. Kamphoven, H.J. Van den Hout, L.A. Severijnen, P.A. van Doorn, and A.J. Reuser et al. Morphological changes in muscle tissue of patients with infantile Pompe's disease receiving enzyme replacement therapy Muscle Nerve 27 2003 743 751 (Pubitemid 36667485)
152. S.N. Prater, S.G. Banugaria, S.M. DeArmey, E.G. Botha, E.M. Stege, and L.E. Case et al. The emerging phenotype of long-term survivors with infantile Pompe disease Genet Med 14 2012 800 810 doi: 10.1038/gim.2012.44 Epub 2012 Apr 26
153. Lumizyme [package, insert]. Cambridge: Genzyme Corporation; 2010.
154. Güngör D, Kruijshaar ME, Plug I, D'Agostino Sr RB, Hagemans ML, van Doorn PA, et al. Impact of enzyme replacement therapy on survival in adults with Pompe disease: Results from a prospective international observational study. Orphanet J Rare Dis. 2013;8:49.
155. M. Rossi, G. Parenti, R. Della Casa, A. Romano, G. Mansi, and AgovinoT et al. Long-term enzyme replacement therapy for Pompe disease with recombinant human α-glucosidase derived from Chinese hamster ovary cells J Child Neurol 22 2007 565 573 (Pubitemid 46951500)
156. D. Orlikowski, N. Pellegrini, H. Prigent, P. Laforêt, R. Carlier, and P. Carlier et al. Recombinant human acid alpha-glucosidase (rhGAA) in adult patients with severe respiratory failure due to Pompe disease Neuromuscul Disord 21 2011 477 482
157. K. Laloui, C. Wary, R.Y. Carlier, J.Y. Hogrel, C. Caillaud, and P. Laforêt Making diagnosis of Pompe disease at a presymptomatic stage: To treat or not to treat? Neurology 77 2011 594 595
158. A. Joseph, K. Munroe, M. Housman, R. Garman, and S. Richards Immune tolerance induction to enzyme replacement therapy by co-administration of short-term, low-dose methotrexate in a murine Pompe disease model Clin Exp Immunol 152 2008 138 146 (Pubitemid 351347554)
159. B. Sun, A. Bird, S.P. Young, P.S. Kishnani, Y.T. Chen, and D.D. Koeberl Enhanced response to enzyme replacement therapy in Pompe disease after the induction of immune tolerance Am J Hum Genet 81 2007 1042 1049 (Pubitemid 47580255)
160. N.J. Mendelsohn, Y.H. Messinger, A.S. Rosenberg, and P.S. Kishnani Elimination of antibodies to recombinant enzyme in Pompe's disease N Engl J Med 360 2009 194 195
161. S.G. Banugaria, S.N. Prater, T.T. Patel, S.M. Dearmey, C. Milleson, and K.B. Sheets et al. Algorithm for the early diagnosis and treatment of patients with cross reactive immunologic material-negative classic infantile Pompe disease: A step towards improving the efficacy of ERT PLoS One 8 2013 e67052
162. N. Raben, T. Jatkar, A. Lee, N. Lu, S. Dwivedi, and K. Nagaraju et al. Glycogen stored in skeletal but not in cardiac muscle in acid alphaglucosidase mutant (Pompe) mice is highly resistant to transgene-encoded human enzyme Mol Ther 6 2002 601 608 (Pubitemid 35363692)
163. N. Raben, M. Danon, A.L. Gilbert, S. Dwivedi, B. Collins, and B.L. Thurberg et al. Enzyme replacement therapy in the mouse model of Pompe disease Mol Genet Metab 80 2003 159 169 (Pubitemid 37272242)